New Harvard research suggests that lithium is a naturally occurring brain mineral, and that lithium levels drop early in Alzheimer’s disease because lithium gets trapped inside amyloid plaques, leaving the rest of the brain functionally “lithium deficient.” Nature
In mouse models, lithium deficiency accelerates amyloid plaques, tau tangles, and memory loss, while restoring lithium reverses pathology and improves cognition. Nature
A novel lithium salt that doesn’t bind to amyloid – lithium orotate, reversed memory deficits and reduced plaques and tangles in Alzheimer’s mice at very low doses, outperforming lithium carbonate in those models. Harvard Gazette
Observational human studies suggest higher trace lithium in drinking water is associated with lower dementia risk, hinting that chronic low lithium exposure may be protective for the brain. PMC
The brain’s “missing mineral”? How lithium entered the Alzheimer’s conversation.
For years, lithium was mostly known as a high-dose prescription drug for bipolar disorder. Recently, it’s been getting a very different kind of attention, as a trace brain mineral that might help protect against cognitive decline and Alzheimer’s disease, especially in its low-dose and lithium orotate forms.
A 2025 Nature paper from a Harvard-led team changed the tone of the entire conversation. Researchers showed that:
The brain naturally contains lithium at very low levels.
In Alzheimer’s disease, lithium gets sucked into amyloid plaques, leaving other regions relatively depleted, a state the authors describe as lithium deficiency in the brain. Nature
This idea, that you can be “lithium deficient” at the brain level, even if your blood levels look normal, is now reshaping how scientists think about cognitive decline.
What is lithium orotate, and how is it different from prescription lithium?
Lithium Carbonate (and sometimes lithium citrate) is the standard prescription form used for mood disorders. Doses are relatively high, blood levels must be monitored, and there is a narrow therapeutic window due to potential kidney and thyroid side effects.
Lithium Orotate is a different lithium salt, often sold as a dietary supplement at much lower doses (typically 1–10 mg elemental lithium per day). Several lines of evidence suggest it behaves differently:
In classic animal work from the 1970s, lithium orotate produced higher brain lithium levels than lithium carbonate at equal doses, likely due to slower clearance, although those early doses were high and raised safety concerns. Alzheimer’s Drug Discovery Foundation
More recent discussions and reviews argue that, at microdoses, lithium orotate appears to deliver lithium more efficiently to the brain than lithium carbonate, potentially increasing bioavailable lithium in neural tissue while keeping blood levels low. Peter Attia
That doesn’t automatically make it “better” or “safer” but it does make lithium orotate different, especially in the context of brain-targeted, low-dose strategies.
The new story: lithium deficiency in the brain and Alzheimer’s pathology
The Nature/Harvard study looked at both human brain tissue and mouse models of Alzheimer’s disease. Key findings: Nature
Lithium is trapped in amyloid plaques.
In brain samples from people with mild cognitive impairment (MCI) and Alzheimer’s, lithium was concentrated inside amyloid plaques, while the surrounding “plaque-free” tissue had significantly lower lithium levels.Lower non-plaque lithium correlated with worse cognition.
Individuals with lower lithium levels in plaque-free cortex had poorer memory and global cognitive scores, even before full-blown Alzheimer’s.Lithium deficiency in mice accelerates pathology.
When mice were fed a lithium-deficient diet, they developed:More amyloid plaques
More phosphorylated tau (the protein that forms tangles)
Faster synapse loss and myelin breakdown
Earlier and more severe memory deficits in tasks like the Morris water maze
In other words, lithium deficiency itself was enough to push the brain toward Alzheimer-like changes.
Replacement lithium reversed disease markers.
When lithium was reintroduced at very low doses, pathology and cognitive decline were significantly improved in Alzheimer’s mouse models and aging wild-type mice.
This is where lithium orotate enters the picture.
Lithium orotate: avoiding amyloid plaques and restoring memory in mice
One of the most intriguing pieces of the Harvard research is that not all lithium salts behave the same way in the diseased brain:
The team tested different lithium compounds in mouse models and found that a specific lithium salt that doesn’t get trapped by amyloid plaques restored memory and reduced pathology far more effectively than lithium carbonate. Harvard Medical School
Follow-up summaries from NIH, PBS, and independent clinicians identify this compound as lithium orotate, a form already sold as a low-dose supplement. National Institutes of Health (NIH)
In those animal studies, low-dose lithium orotate:
Reduced amyloid plaque burden and tau tangles in Alzheimer’s mouse models. National Institutes of Health (NIH)
Preserved synapses and myelin, markers of brain connectivity and resilience. Nature
Restored memory performance to near-young levels, even when started later in the disease course. Chemical & Engineering News
This is the scientific root of the phrase you used earlier, “the brain’s new super supplement,” but it’s crucial to remember: these are animal data, not yet confirmed in large human trials.
Observational evidence: trace lithium and dementia risk in humans
While we don’t yet have big randomized trials of lithium orotate in people with Alzheimer’s, we do have intriguing population-level data:
Multiple studies have found that regions with slightly higher lithium in drinking water tend to have lower rates of dementia or slower cognitive decline over time. Psychiatry Redefined
A 2024 systematic review concluded that trace lithium exposure, even at very low doses, may be associated with reduced dementia risk, challenging the old assumption that only high, “psychiatric” doses are meaningful for the brain. PMC
These are associations, not proof of causation, and they can be confounded by many factors (diet, health care access, socioeconomic status). But they fit neatly with the lab data: too little lithium in the brain seems to go hand-in-hand with higher vulnerability to neurodegeneration.
Mechanisms: how lithium may protect the brain
Reviews of lithium’s neurobiology outline several mechanisms that could help explain why both deficiency is harmful and replacement can be protective: Psychiatry Redefined
Inhibition of GSK-3β, reducing tau hyperphosphorylation and tau tangles
Lower amyloid-beta production and plaque accumulation
Reduced neuroinflammation and oxidative stress
Support for synaptic plasticity and neurogenesis
Potential stabilization of calcium and mitochondrial function, important for cell survival
Lithium orotate, by delivering lithium into the brain while avoiding sequestration into amyloid plaques, might magnify these benefits at very low doses, at least in animals.
So… should you take lithium orotate for brain health?
This is where science and caution must meet.
What we can reasonably say (as of late 2025)
There is strong animal evidence that:
Brain lithium deficiency accelerates Alzheimer-like changes.
Low-dose lithium, especially lithium orotate, can reverse pathology and memory loss in mice.
There is growing epidemiological evidence that trace lithium exposure in water correlates with lower dementia risk.
Early human work with low-dose lithium (including orotate) shows brain uptake on MRI and promising signals, but not definitive proof of dementia prevention. ScienceDirect
What we cannot say yet
We cannot honestly claim that lithium orotate prevents, treats, or cures Alzheimer’s in humans. No large, long-term randomized trials have proven that.
“Lithium deficiency” is not yet a standard clinical diagnosis like iron deficiency anemia; it’s an emerging concept based on brain imaging and pathology work.
Practical, safety-first guidance
If someone is considering low-dose lithium orotate as part of a brain longevity strategy, a few principles make sense:
Work with a knowledgeable practitioner (especially if you have kidney disease, thyroid issues, cardiovascular disease, or are taking prescription lithium, diuretics, ACE inhibitors, or NSAIDs regularly).
Typical supplement doses (1–5 mg elemental lithium) are far below psychiatric doses, but that doesn’t make them universally safe or appropriate.
For now, lithium orotate should be considered experimental for Alzheimer’s, best used as one possible tool in a bigger brain-health strategy:
B-vitamin–driven methylation support
Anti-inflammatory nutrition
Blood sugar and vascular health
Sleep, stress, detox support, and movement
You’re already doing this broader foundation work with your Brilliant B+ and other AgeImmune formulas, Lithium Orotate, if you introduce it, naturally plugs into that bigger picture rather than replacing it.
FAQ: Lithium Orotate, Brain Lithium Deficiency & Alzheimer’s
1. Is “lithium deficiency in the brain” a real thing?
Emerging research suggests yes, at least in the context of Alzheimer’s. Post-mortem human studies show lithium is pulled into amyloid plaques, leaving non-plaque tissue relatively depleted. In mice, deliberately reducing dietary lithium accelerated plaques, tangles, and memory loss. Nature
2. Is lithium orotate better than lithium carbonate for brain health?
“Better” depends on the goal. For bipolar disorder, lithium carbonate remains the standard, carefully dosed and monitored. For low-dose, brain-focused prevention strategies, animal and mechanistic data suggest lithium orotate may:
Avoid being trapped by amyloid plaques
Deliver lithium more evenly throughout the brain at microdoses
But this advantage is not yet clinically proven in large human trials, so we have to treat it as promising but unproven. Harvard Medical School
3. Can lithium orotate prevent or reverse Alzheimer’s in humans?
We cannot say that yet. In mice, lithium orotate at low doses reduced plaques and tangles and restored memory even in established disease models. In humans, we only have observational and small early-phase data. We’re still waiting on robust, controlled clinical trials before making that claim. ScienceDirect
4. What dose of lithium orotate is being studied for cognitive support?
Most brain-health discussions focus on microdoses, often in the range of 1–5 mg elemental lithium per day, sometimes delivered as lithium orotate. A 2024 7Li-MRI study used 5 mg/day in healthy volunteers and confirmed measurable brain uptake. Higher doses approach the territory where kidney and thyroid side effects must be monitored very carefully. Alzheimer’s Drug Discovery Foundattion
5. Isn’t lithium toxic? How is low-dose different?
At high prescription doses, lithium can stress the kidneys and thyroid, which is why psychiatrists monitor blood levels frequently. At microdoses, total exposure is closer to what people naturally get from drinking water and food in certain regions. That said, “low dose” is not exactly the same as “risk-free,” especially if you already have kidney or thyroid issues, hence the importance of personalized guidance. Alzheimer’s Drug Discovery Foundation
References
- Aron L, et al. Lithium deficiency and the onset of Alzheimer’s disease. Nature. 2025. Nature
- Harvard Medical School. Could Lithium Explain and Treat Alzheimer’s Disease? 2025. Harvard Medical School
- NIH Research Matters. Lithium levels tied to Alzheimer’s disease and dementia. 2025. National Institutes of Health (NIH)
- Fraiha-Pegado J, et al. Trace lithium levels in drinking water and risk of dementia: a systematic review. Int J Bipolar Disord. 2024. PMC
- Kessing LV, et al. Association of lithium in drinking water with the incidence of dementia. JAMA Psychiatry. 2017. JAMA Network
- Neal MA, et al. Human brain 7Li-MRI following low-dose lithium dietary supplementation. 2024. ScienceDirect
- Forlenza OV, et al. Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer’s Disease. Front Neurol. 2014. PMC
- de Jesus RV, et al. Lithium and neuroprotection: a review of molecular targets. 2025. PMC
- Singulani MP, et al. Lithium and disease modification: a systematic review in Alzheimer’s models. 2024. ScienceDirect
- National Geographic, Washington Post, PBS, STAT, C&EN, various 2025 reports summarizing lithium – Alzheimer’s research and lithium orotate findings. The Washington Post
